INSPIRE IVF Public Company LimitedSET: IVF🇹🇭 TH

News & Press Releases

SET Announcements

12 Nov 2026

Financial Performance Quarter 3 (F45) (Reviewed) (Revised)

Read the full announcement on the SET website ↗
12 Nov 2026

Financial Statement Quarter 3/2026 (Reviewed)

Read the full announcement on the SET website ↗
12 Nov 2026

Management Discussion and Analysis Quarter 3 Ending 30 Sep 2026

Read the full announcement on the SET website ↗
12 Nov 2026

Financial Performance Quarter 3 (F45) (Reviewed)

Read the full announcement on the SET website ↗
13 Aug 2026

Notification of the Resolutions of the Board of Directors' Meeting No. 4/2026 regarding a Connected Transaction

Read the full announcement on the SET website ↗
13 Aug 2026

Financial Performance Quarter 2 (F45) (Reviewed)

Read the full announcement on the SET website ↗
13 Aug 2026

Management Discussion and Analysis Quarter 2 Ending 30 Jun 2026

Read the full announcement on the SET website ↗
13 Aug 2026

Financial Statement Quarter 2/2026 (Reviewed)

Read the full announcement on the SET website ↗
7 Aug 2026

Report on the results of the Exercise of IVF-W1 (F53-5) (Revised)

Read the full announcement on the SET website ↗
6 Aug 2026

Report on the results of the Exercise of IVF-W1 (F53-5)

Read the full announcement on the SET website ↗
21 Jul 2026

Report on the use of funds from the initial public offering (IPO) as of June 30, 2026

Read the full announcement on the SET website ↗
15 Jul 2026

Notification the exercise of IVF-W1 (Revised)

Read the full announcement on the SET website ↗
14 Jul 2026

Notification the exercise of IVF-W1

Read the full announcement on the SET website ↗
1 Jul 2026

Notification of the Resolutions of the Board of Directors' Meeting No. 3/2569 Regarding the Approval of Eternity Healthcare 369., Ltd (Revised)

Read the full announcement on the SET website ↗
29 Jun 2026

Information Memorandum Description, Condition and Major Characteristics of Warrant to Purchase Ordinary Shares of INSPIRE IVF Public Company Limited No. 1 (IVF-W1)

Read the full announcement on the SET website ↗
24 Jun 2026

Notification of the Resolutions of the Board of Directors' Meeting No. 3/2569 Regarding the Approval of Eternity Healthcare 369., Ltd

Read the full announcement on the SET website ↗
19 May 2026

Report on the results of the sale of warrants offered to All common shares' shareholders (F53-5)

Read the full announcement on the SET website ↗
14 May 2026

Financial Performance Quarter 1 (F45) (Reviewed)

Read the full announcement on the SET website ↗
14 May 2026

Management Discussion and Analysis Quarter 1 Ending 31 Mar 2026

Read the full announcement on the SET website ↗
14 May 2026

Financial Statement Quarter 1/2026 (Reviewed)

Read the full announcement on the SET website ↗
6 May 2026

The publication of Minutes of the 2026 Annual General Meeting of Shareholders

Read the full announcement on the SET website ↗
23 Apr 2026

Form to Report on Names of Members and Scope of Work of the Audit Committee (F24-1)

Read the full announcement on the SET website ↗
23 Apr 2026

Notification on the Resolutions of the 2026 Annual General Meeting of Shareholders

Read the full announcement on the SET website ↗
27 Feb 2026

Date and agenda of the 2026 Annual General Meeting of Shareholders, change of the objectives for the utilization of IPO proceeds, omission of dividend payment, issuance of warrants to purchase ordinary shares, and capital increase.

Read the full announcement on the SET website ↗
27 Feb 2026

Management Discussion and Analysis Yearly Ending 31 Dec 2025

Read the full announcement on the SET website ↗
27 Feb 2026

Financial Statement Yearly 2025 (Audited)

Read the full announcement on the SET website ↗
27 Feb 2026

Financial Performance Yearly (F45) (Audited)

Read the full announcement on the SET website ↗
27 Jan 2026

Report on the use of funds from the initial public offering (IPO) as of December 31, 2025

Read the full announcement on the SET website ↗
20 Jan 2026

Notification of the Results of Shareholders' Rights to Propose Agenda Items, Nominate Directors, and Submit Questions in Advance for the 2026 Annual General Meeting of Shareholders

Read the full announcement on the SET website ↗
13 Nov 2025

Notification of Appointment of Audit Committee (Revised)

Read the full announcement on the SET website ↗
11 Nov 2025

Notification of Change of Directors

Read the full announcement on the SET website ↗
11 Nov 2025

Management Discussion and Analysis Quarter 3 Ending 30 Sep 2025

Read the full announcement on the SET website ↗
11 Nov 2025

Financial Performance Quarter 3 (F45) (Reviewed)

Read the full announcement on the SET website ↗
11 Nov 2025

Financial Statement Quarter 3/2025 (Reviewed)

Read the full announcement on the SET website ↗
17 Oct 2025

Providing shareholders the right to propose agendas, nominate qualified director candidates, and submit questions in advance for the 2026 Annual General Meeting of Shareholders.

Read the full announcement on the SET website ↗